Randomized Evaluation of TriGuard 3 Cerebral Embolic Protection After Transcatheter Aortic Valve Replacement REFLECT II

Overview of attention for article published in JACC: Cardiovascular Interventions, March 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

news: 1 news outlet

twitter: 10 X users

Readers on

mendeley: 109 Mendeley

So far, Altmetric has seen 11 X posts from 10 X users, with an upper bound of 145,877 followers.

RT @JACCJournals: REFLECT II trial of TriGUARD 3 cerebral embolic protection device during #TAVR: * Was stopped early * Shown to be safe *…

RT @YaleCardiology: A randomized study led by Alexandra Lansky, MD and investigators evaluates the safety and efficacy of the TriGUARD 3 ce…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 7 additional X posts.